Clinical trial
Hydrogen Sulfide as Prognostic Factor
NCT01088490 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydrogen Sulfide as Prognostic Factor
- Lead sponsor
- University Medical Centre Ljubljana
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- January 31, 2014
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mortality, shock